English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessMarketsDiscovery Series: New capacity, R&D uptrend to kickstart new earnings cycle for this healthcare proxy

    Discovery Series: New capacity, R&D uptrend to kickstart new earnings cycle for this healthcare proxy

    Tarsons Products is well positioned to gain from the surge in R&D investments in new molecules in the labware industry and demand for diagnostic services.

    Anubhav Sahu
    Anant Chaudhary
    January 16, 2024 / 10:35 IST
    The diagnostics sector is witnessing a significant demand upsurge due to preventive healthcare and preference for certified labs
    • PRO Panorama

      Moneycontrol Pro Panorama | Fiat crisis

      Oct 6, 2025 / 03:28 PM IST

      In Moneycontrol Pro Panorama October 6 edition: India missing out on the emerging markets party, can earnings season revive the ma...

      Read Now
    Unlock This Article

    Are you a PRO subscriber? Sign In

    What Do You Get

    • Ad free Experience

      Seamless navigation, faster responses.

    • Expert Perspective

      Explore 230+ exclusive editorials every month

    • +

      Uncover Insights from World-Renowned Experts and Journalists

    • Actionable Insights

      40+ weekly investment ideas + 3 to 4 daily technical calls

    • Virtual Events

      Exclusive Live Webinars for Expert Trading & Investment Strategies!

    • Newsletters

      Stay ahead with daily and weekly insights

    View Offers

    Unlock exclusive discounts

    Disclosure & Disclaimer

    This Research Report / Research Recommendation has been published by Moneycontrol Dot Com India Limited (hereinafter referred to as “MCD”) which is a registered Investment Advisor under the Securities and Exchange Board of India (Investment Advisers) ...Read More